People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

Which European healthcare stocks are most attractive right now? We asked Seeking Alpha analysts Edmund Ingham, Wolf Report ...

Dr. Heather Rosen By Heather Rosen, PhD Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 ...

Novo Nordisk (NYSE: NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

For individuals living with type 2 diabetes or struggling with weight loss, Rybelsus has become a popular name in the realm of oral GLP-1 receptor agonists. While its effectiveness in lowering blood ...

Weight loss drugs, already a relatively new and revolutionary concept within the medical industry, are shaking things up once again. Move over Ozempic, pharmaceutical giant Eli Lilly […] ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Katie Price said she was "heartbroken" as she issued an update on her son, Harvey. The 46-year-old is the proud mum to five ...

As Katie Price issues a heartbreaking update concerning the health woes of her eldest son Harvey, the Mirror takes a look at ...

Americans shelled out an estimated $71 billion for weight-loss drugs in 2023 - that is as much as the U.S. government disbursed in foreign aid the same year, according to ForeignAssistance.gov.

Before you take a shot of apple cider vinegar, learn more about its potential benefits and side effects. We spoke to registered dietitians to understand this health trend.